Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Jun 06, 2022 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,434,958 | Feb 28, 2023, 12:29 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Oct 21, 2022 | Option Exercise | $5.94 | 47,999 | 285,114 | 1,485,168 | Feb 28, 2023, 12:23 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Jun 16, 2022 | Option Exercise | $5.00 | 2,211 | 11,055 | 1,437,169 | Feb 28, 2023, 12:21 PM | |
KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Director | Nov 29, 2022 | Option Exercise | $0.00010 | 7,176 | 1 | 2,284,612 | Nov 30, 2022, 04:40 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Oct 21, 2022 | Option Exercise | $5.94 | 47,999 | 285,114 | 1,481,927 | Oct 25, 2022, 04:57 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Jun 06, 2022 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,433,928 | Aug 25, 2022, 03:25 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Mar 25, 2021 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,431,717 | Jun 09, 2021, 01:46 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Mar 25, 2021 | Option Exercise | $5.00 | 2,211 | 11,055 | 1,433,928 | Jun 09, 2021, 01:42 PM | |
URGN | UroGen Pharma Ltd. | Nussbaum Ran | Director | Mar 24, 2021 | Option Exercise | $5.00 | 1,030 | 5,150 | 1,465,199 | Apr 22, 2021, 05:18 PM | |
KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Director | Nov 17, 2020 | Buy | $50.00 | 60,000 | 3,000,000 | 2,288,151 | Nov 19, 2020, 04:40 PM | |
KROS | Keros Therapeutics, Inc. | Nussbaum Ran | Director | Apr 13, 2020 | Buy | $16.00 | 437,499 | 6,999,984 | 2,261,517 | Apr 13, 2020, 05:16 PM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | Jan 16, 2020 | Option Exercise | $20.00 | 8,744,820 | 174,896,400 | 0 | Jan 16, 2020, 03:57 PM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | Dec 24, 2019 | Option Exercise | $3.22 | 1,815,015 | 5,844,003 | 4,362,224 | Dec 27, 2019, 08:48 PM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | Sep 12, 2019 | Option Exercise | $1.75 | 114,286 | 200,001 | 3,538,592 | Sep 16, 2019, 04:42 PM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | Jun 27, 2019 | Buy | $9.75 | 307,692 | 2,999,997 | 3,482,224 | Jul 01, 2019, 11:50 AM | |
ELOX | Eloxx Pharmaceuticals, Inc. | Nussbaum Ran | Director | Jun 24, 2019 | Buy | $9.00 | 200,000 | 1,800,000 | 1,049,310 | Jun 26, 2019, 04:51 PM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | Jul 13, 2018 | Buy | $5.50 | 181,818 | 999,999 | 3,348,676 | Oct 22, 2018, 02:54 PM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | May 18, 2018 | Buy | $3.29 | 8,611 | 28,330 | 8,611 | May 22, 2018, 09:22 AM | |
ARQL | ARQULE INC | Nussbaum Ran | Director | May 18, 2018 | Buy | $3.29 | 8,611 | 28,330 | 8,611 | May 18, 2018, 05:41 PM | |
ELOX | Eloxx Pharmaceuticals, Inc. | Nussbaum Ran | Director | Apr 30, 2018 | Buy | $9.75 | 350,000 | 3,412,500 | 962,504 | May 01, 2018, 04:34 PM | |
ELOX | Eloxx Pharmaceuticals, Inc. | Nussbaum Ran | Director | Mar 21, 2018 | Buy | $7.55 | 6,600 | 49,830 | 786,919 | Mar 23, 2018, 04:20 PM | |
ELOX | Eloxx Pharmaceuticals, Inc. | Nussbaum Ran | Director | Mar 22, 2018 | Buy | $8.00 | 6,000 | 48,000 | 789,878 | Mar 23, 2018, 04:20 PM | |
KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | May 09, 2017 | Buy | $69.11 | 9,832 | 679,474 | 3,520 | May 11, 2017, 02:02 PM | |
KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Jun 01, 2015 | Sale | $55.34 | 80,760 | 4,469,230 | 236,228 | Jun 03, 2015, 07:40 PM | |
KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Jun 02, 2015 | Sale | $55.36 | 224,674 | 12,437,229 | 24,070 | Jun 03, 2015, 07:40 PM | |
KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Mar 27, 2015 | Sale | $61.24 | 77,873 | 4,769,020 | 216,064 | Mar 31, 2015, 08:38 PM | |
KITE | Kite Pharma, Inc. | Nussbaum Ran | Director | Mar 30, 2015 | Sale | $59.91 | 115,857 | 6,941,468 | 149,116 | Mar 31, 2015, 08:38 PM |